Is efavirenz/emtricitabine/tenofovir (EFV+FTC+TDF, Viraday) on the market?

Efavirenz/Emtricitabine/Tenofovir (EFV+FTC+TDF, Viraday) is an antiviral drug used to treat adults infected with human immunodeficiency virus-1 (HIV-1), the virus that causes acquired immunodeficiency syndrome (AIDS). Efavirenz/emtricitabine/tenofovir are combination drugs.

Efavirenz/Emtricitabine/Tenofovir is used only in patients who have responded well to current HIV treatments and in patients with HIV infection who have not developed resistance to treatment or are unlikely to respond to any of the active substances in the medicine containing the active substanceEfavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate, for "generic drug". This means it contains the same active substance and works in the same way as the European Union (EU)-approved "reference medicine" Atripla, which has been shown to be of comparable quality and to be bioequivalent to Atripla.

Efavirenz/Emtricitabine/Tenofovir (Viraday) is not currently on the market in China, so it is not included in medical insurance. Patients cannot purchase it domestically and need to purchase it through overseas purchasing channels. The cheaper ones abroad are mainly Indian generic drugs. Their drug ingredients are basically the same as those of the original drugs. The specifications (600MG+200MG+300MG)*30 per box may cost more than 300 RMB (the price may fluctuate due to the exchange rate). For specific drug prices and drug information, please consult Yaode Medical Consultant.